TipRanks
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF
US Market
NWPHF
Newron Pharmaceuticals SpA
RESEARCH TOOLSreports

Newron Pharmaceuticals SpA (NWPHF) Stock News & Sentiment

20 Followers
Newron presses on with Evenamide Phase 3 as FDA halts U.S. arm over safety signal
Premium
Company Announcements
Newron presses on with Evenamide Phase 3 as FDA halts U.S. arm over safety signal
3d ago
Newron presses on with ENIGMA-TRS program as FDA clinical hold prompts safety review
Premium
Company Announcements
Newron presses on with ENIGMA-TRS program as FDA clinical hold prompts safety review
3d ago
Newron Faces Ongoing FDA Hold on U.S. Arm of Key Evenamide Schizophrenia Trial
Premium
Company Announcements
Newron Faces Ongoing FDA Hold on U.S. Arm of Key Evenamide Schizophrenia Trial
15d ago
Newron Bolsters Finances as Evenamide Phase 3 Program Advances Toward 2027 Readouts
Premium
Company Announcements
Newron Bolsters Finances as Evenamide Phase 3 Program Advances Toward 2027 Readouts
19d ago
Newron Ramps Up Evenamide Phase 3 as Financing and Patent Wins Offset Wider Loss
Premium
Company Announcements
Newron Ramps Up Evenamide Phase 3 as Financing and Patent Wins Offset Wider Loss
19d ago
Newron secures EUR 5.5 million tranche to fund Phase 3 Evenamide program
Premium
Company Announcements
Newron secures EUR 5.5 million tranche to fund Phase 3 Evenamide program
1M ago
Newron Bolsters Phase 3 Schizophrenia Program with EUR 5.5 Million Share Subscription
Premium
Company Announcements
Newron Bolsters Phase 3 Schizophrenia Program with EUR 5.5 Million Share Subscription
1M ago
More NWPHF News >

NWPHF News on the Web

Analysts Conflicted on These Healthcare Names: CSL (OtherCMXHF) and Newron Pharmaceuticals SpA (OtherNWPHF)
TipRanks News
Bullish
Newron Pharma price target lowered to CHF 19 from CHF 35 at Roth Capital
TipRanks News
Neutral
Newron Faces Ongoing FDA Hold on U.S. Arm of Key Evenamide Schizophrenia Trial
TipRanks News
Neutral
Newron secures EUR 5.5 million tranche to fund Phase 3 Evenamide program
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Newron Pharmaceuticals SpA (OtherNWPHF) and Boston Scientific (BSX)
TipRanks News
Bullish
Newron, FDA in constructive talks over U.S. trial halt for schizophrenia drug Evenamide
TipRanks News
Neutral
H.C. Wainwright Sticks to Its Buy Rating for Newron Pharmaceuticals SpA (NWPHF)
TipRanks News
Bearish
Newron Pharmaceuticals’ Earnings Call Signals Pivotal Year Ahead
TipRanks News
Bullish

News Score - Last 7 Days

Negative
NWPHF
Sector Average
Media Buzz
This Week4 articles
Weekly Average1.25 articles
News Sentiment
This Week33%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NWPHF’s Media Buzz Sentiment?
4 articles about NWPHF were published this week. In an average week, 1.25 articles are published.
    What is NWPHF’s weekly average amount of articles?
    In an average week, 1.25 articles about NWPHF are published.
      What is NWPHF’s News Sentiment?
      33% of articles about NWPHF were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CMXHFCSL
        RZLTRezolute
        AMGNAmgen
        PMCUFPro Medicus Limited
        ABTAbbott Laboratories
        Showing the stocks with the most bullish news sentiment over the past week